Harfst & Associates’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-4,899
Closed -$1.1M 116
2025
Q1
$1.1M Sell
4,899
-6,802
-58% -$1.52M 0.25% 48
2024
Q4
$2.68M Sell
11,701
-200
-2% -$45.7K 0.56% 29
2024
Q3
$2.91M Sell
11,901
-386
-3% -$94.2K 0.65% 25
2024
Q2
$2.35M Sell
12,287
-32
-0.3% -$6.13K 0.55% 31
2024
Q1
$2.44M Buy
12,319
+1,492
+14% +$295K 0.58% 34
2023
Q4
$1.86M Sell
10,827
-168
-2% -$28.9K 0.49% 50
2023
Q3
$1.63M Buy
10,995
+73
+0.7% +$10.8K 0.46% 58
2023
Q2
$2.39M Buy
10,922
+64
+0.6% +$14K 0.64% 29
2023
Q1
$2.38M Sell
10,858
-41
-0.4% -$8.98K 0.68% 22
2022
Q4
$2.27M Buy
10,899
+86
+0.8% +$17.9K 0.65% 21
2022
Q3
$2.36M Buy
10,813
+522
+5% +$114K 0.71% 18
2022
Q2
$2.16M Sell
10,291
-679
-6% -$142K 0.61% 19
2022
Q1
$2.66M Buy
10,970
+248
+2% +$60.1K 0.62% 20
2021
Q4
$2.79M Buy
10,722
+2,162
+25% +$563K 0.71% 17
2021
Q3
$2.26M Sell
8,560
-692
-7% -$182K 0.62% 18
2021
Q2
$2.28M Sell
9,252
-801
-8% -$197K 0.66% 19
2021
Q1
$1.95M Buy
10,053
+2,865
+40% +$556K 0.59% 25
2020
Q4
$1.53M Buy
7,188
+948
+15% +$201K 0.56% 21
2020
Q3
$1.07M Sell
6,240
-425
-6% -$72.8K 0.45% 33
2020
Q2
$1.28M Sell
6,665
-156
-2% -$29.9K 0.55% 20
2020
Q1
$1M Buy
6,821
+183
+3% +$26.9K 0.51% 20
2019
Q4
$1.03M Buy
6,638
+138
+2% +$21.4K 0.4% 28
2019
Q3
$878K Buy
6,500
+115
+2% +$15.5K 0.36% 29
2019
Q2
$779K Buy
6,385
+392
+7% +$47.8K 0.32% 33
2019
Q1
$623K Buy
5,993
+892
+17% +$92.7K 0.27% 43
2018
Q4
$580K Buy
5,101
+359
+8% +$40.8K 0.28% 31
2018
Q3
$546K Buy
4,742
+165
+4% +$19K 0.23% 38
2018
Q2
$474K Buy
+4,577
New +$474K 0.2% 40